Business
Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), is pleased to announce that its Grangemouth, UK facility has received updated MHRA GMP certificates following a successful compliance report and desktop inspection.
About this update from Piramal Pharma Limited
[{"type":"list","items":[{"val":[{"type":"text","content":"These certificates cover all activities conducted in the site's Helix building, including its supporting warehouse and laboratory areas.","length":140,"tagName":"p"}]},{"val":[{"type":"text","content":"The certificates were granted following the site's submission of an MHRA GMP compliance report and the completion of a successful desktop inspection.","length":153,"tagName":"p"}]},{"val":[{"type":"text","content":"The updated certificates are valid for three years.","length":51,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":344,"olType":false},{"type":"text","content":"MUMBAI, India, Nov. 19, 2025 /PRNewswire/ -- Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), is pleased to announce that its Grangemouth, UK facility has received updated MHRA GMP certificates following a successful compliance report and desktop inspection.","length":375,"tagName":"p"},{"type":"image","alt":"Peter DeYoung, CEO, Piramal Global Pharma","displaySize":"","headline":null,"caption":"Peter DeYoung, CEO, Piramal Global Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":320,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/8cee6446d10bb7c2f44f2d30673bdabe"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ADcLUnZeg4YFqTRUI3KTSA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTgwMDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/8cee6446d10bb7c2f44f2d30673bdabe","width":320,"height":400}},"href":"https://mma.prnewswire.com/media/2827195/Peter_DeYoung_Piramal.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"These certificates encompass all activities within the facility's Helix building, which specializes in clinical and commercial drug substance manufacture and testing. They also extend to the building's supporting warehouse and laboratory areas. Together with the site's existing GMP certificates, the updated certificates ensure Grangemouth is well-equipped to support its clients' programs and regulatory filings.","length":430,"tagName":"p"},{"type":"text","content":"As Piramal Pharma Solutions' dedicated antibody-drug conjugate (ADC) development and manufacturing facility, Grangemouth offers comprehensive sol...